About
Chordate Medical is a medical technology company that has developed, patented and CE-marked a neuromodulation and drug-free treatment technology for chronic migraine and chronic nasal congestion (rhinitis), Ozilia™ Migraine. The treatment has clinically proven efficacy according to a recent study, and is marketed in selected markets in the EU and the Middle East. Chordate Medical is listed on Nasdaq First North Growth Market Stockholm.
Technologies
Outlook
Google Font API
WordPress.org
Nginx
Google Tag Manager
YouTube
Twitter Advertising
Google Dynamic Remarketing
Gravity Forms
Facebook Login (Connect)
DoubleClick Conversion
Facebook Widget
DoubleClick
Mobile Friendly
Facebook Custom Audiences
Linkedin Marketing Solutions
Domo
Sisense
KNIME
Circle
Keywords
medical equipment manufacturing
medical devices
medical equipment and supplies manufacturing
treatment for headache
clinical evidence
market expansion
non-drug treatment
intranasal neuromodulation
medical technology
drug-free therapy
neurological treatment
clinical studies
healthcare market
international patents
migraine prevention
market strategy
minimally invasive device
global patent coverage
ce-marked
healthcare
treatment efficacy
services
patient care
patient benefits
patent portfolio
kinetic oscillation stimulation
chronic rhinitis
non-pharmacological therapy
migraine treatment
medical innovation
Company Information
-
Employees 13
-
Founded 2005
-
Annual Revenue $109000
Location
20 Kistagangen, Stockholm, Stockholm County, Sweden, 164 40
